SEC Form 4 · accession 0001170362-16-000008
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip M Schneider
Director
Period of report
Jun 13, 2016
Accepted (ET)
Jun 15, 2016 · 8:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.00 | Jun 13, 2016 | A | 125,000 | A | — | Jun 13, 2023 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 13, 2016, and are exercisable once vested.